Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Unknown × Lymphoma, B-Cell × Clear all

Phase

Phase 1 31 Phase 2 21 Phase 1/2 18 Phase EARLY_PHASE1 12 Phase NA 5 Phase 4 2 Phase 3 1 Phase 2/3 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 23 Carcinoma, Hepatocellular 22 Colorectal Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Stomach Neoplasms 15 Neoplasms 15 Leukemia, Myeloid, Acute 13 Rectal Neoplasms 10 Prostatic Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Colonic Neoplasms 9 Neoplasm Metastasis 7 Leukemia 7 NSCLC 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Recurrence 4 Pancreatic Neoplasms 4 Head and Neck Neoplasms 4 Glioblastoma 4 Gestational Trophoblastic Disease 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Stomatitis 3 Small Cell Lung Carcinoma 3 Polycystic Ovary Syndrome 3 Pain, Postoperative 3 Pain 3 Nasopharyngeal Carcinoma 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03391726 2018-01-05

CCFRRBL

Fujian Medical University

Phase 2/3 Unknown

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡